Keywords: pfizer, 1st-qtr, net, income, rises, first-quarter, increased
Pfizer 1st-qtr 2001 net income rises 34%
Article | 23 April 2001
First-quarter 2001 net income at Pfizer increased 34% to $2.13 billionand diluted earnings per share rose 32% to $0.33, both excluding the impact of significant ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
